Santosh Shevade’s Post

View profile for Santosh Shevade, graphic

LinkedIn Top AI Voice | Healthcare Innovation | ISB | Digital Health | Biopharma |

💡 💡 GenAI and Skeleton-of-Thought💡 💡 Here's a newly published research introducing the Skeleton-of-Thought (SoT) method, which employs an innovative approach to text generation that might have notable applications across various sectors of pharmaceutical development. ✍🏽 Understanding the Skeleton-of-Thought Method: SoT begins with creating a basic outline—'a skeleton'—that maps out the framework of the intended document. This skeleton is not just a guide but the foundation upon which the entire document can be built. Following this, each segment of the skeleton is expanded simultaneously, rather than in sequence. This parallel expansion allows for multiple parts of the text to be developed at once, which could significantly decrease the time spent on document creation. Finally, these segments are integrated to form a cohesive and comprehensive output. ✍🏽 Some potential applications in pharma R&D operations can be -Regulatory Documentation: Quick and accurate assembly of complex regulatory documents could see significant time savings. -Interactions with Healthcare Professionals (HCPs): Tools that assist HCPs could benefit from faster and more precise information delivery during consultations. -Clinical Trial Reports: Accelerating the preparation of detailed reports could expedite trial phases and overall study conclusions. - Patient Education: Efficient generation of patient-friendly materials that are easy to understand and tailored to specific needs. - Marketing: Creation of marketing materials could become quicker, allowing for rapid response to market changes and needs. How do you see AI like this integrating into your workflows? Keen to hear your thoughts h/t Cameron R. Wolfe, Ph.D. via twitter #generativeai #pharma #tech #innovation

  • No alternative text description for this image
Santosh Shevade

LinkedIn Top AI Voice | Healthcare Innovation | ISB | Digital Health | Biopharma |

7mo
Like
Reply

To view or add a comment, sign in

Explore topics